In the final article of a four-part series on stem cells, the San Francisco Chronicle looks into the California Institute for Regenerative Medicine (CIRM). It features Deepak Srivastava, who highlights the importance of CIRM funding for Gladstone research.
San Francisco Chronicle
San Francisco Business Times
The San Francisco Business Times shares the news of Jennifer Doudna, a pioneer of the revolutionary CRISPR genome-editing technology, launching a laboratory at Gladstone.
The Mercury News
The Mercury News tells the story of college student Delaney Van Riper who suffers from a progressive neurological disorder. She is participating in a pioneering research study led by Bruce Conklin with the hope of overcoming her condition through the use of the gene-editing technology CRISPR.
The New York Times
A recent study suggests viruses might be involved in Alzheimer’s disease. An expert in the field, Lennart Mucke noted to The New York Times, “there have been many speculations that infections contribute to the development of Alzheimer’s. None of them has held up after rigorous cause-effect evaluations.”
CBS Pittsburgh’s local news program highlights Yadong Huang’s different approach to tackling Alzheimer’s disease and explains his game-changing discovery for correcting the deformed structure of a gene called apoE4.
In its list of the most newsworthy stories of the year thus far, BestLife includes—at number 8—the recent Alzheimer’s research findings by Yadong Huang and his team.
CBS San Francisco
An original report by KPIX, the San Francisco Bay Area’s CBS station, features Yadong Huang’s work on Alzheimer’s disease. It explains how he may have found a fix for a major genetic risk factor linked to this devastating malady.
NIH Director's Blog
In a recent post on the NIH Director’s Blog, Francis Collins shares his enthusiasm about the new deep learning approach developed by Steve Finkbeiner and his partners at Google AI.
Google AI Blog
The computer scientists who collaborated with Steve Finkbeiner to develop a deep learning approach called “in silico labeling” share the discovery in this Google Research Blog post.
In this editor’s pick, Forbes highlights Yadong Huang’s recent study and describes how his team identified that a key genetic variant associated with the development of Alzheimer’s operates differently in mice and humans.